StonvexLoading…
StonvexCore line items from ET's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $85.54B | $82.67B | $78.59B | $89.88B |
Operating Income | $9.03B | $9.14B | $8.29B | $7.74B |
Net Income | $4.43B | $4.81B | $3.94B | $4.76B |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $141.29B | $125.38B | $113.70B | $105.64B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.27B | $312.00M | $161.00M | $257.00M |
Free Cash Flow OCF − CapEx | $3.85B | $7.34B | $6.42B | $5.67B |
Shares Outstanding | Not available | Not available | Not available | Not available |